What are the pathognomonic histopathological features for retiform purpura, Disseminated Intravascular Coagulation (DIC), and fulminant hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathognomonic Histopathological Features of Retiform Purpura, DIC, and Fulminant Hepatitis

The pathognomonic histopathological features for retiform purpura include vascular occlusion with thrombi in dermal and subcutaneous vessels, while DIC shows widespread microvascular thrombi with fibrin deposition across multiple organs, and fulminant hepatitis demonstrates massive hepatocyte necrosis with parenchymal collapse.

Retiform Purpura

Retiform purpura represents a livedoid pattern of cutaneous hemorrhage that can result from various underlying pathological processes. The key histopathological features include:

  • Vascular occlusion with thrombi in dermal and subcutaneous vessels, creating the characteristic branching or net-like (retiform) pattern of purpura 1, 2
  • Presence of vascular inflammation when presenting as palpable plaques, distinguishing it from other causes of retiform purpura 1
  • Fibrin thrombi within small vessels of the dermis and subcutaneous tissue 2, 3
  • Variable degrees of endothelial damage depending on the underlying etiology 2

Retiform purpura can be caused by various conditions including vasculitis, microvascular occlusion, thrombotic disorders, and altered coagulation states. When evaluating a patient with retiform purpura, it's crucial to determine whether the underlying pathology is:

  • Inflammatory (vasculitis)
  • Occlusive (thrombosis)
  • Embolic phenomena 2, 3

Disseminated Intravascular Coagulation (DIC)

DIC is characterized by systemic activation of coagulation with distinctive histopathological findings:

  • Widespread microvascular thrombi with fibrin deposition across multiple organs 4
  • Consumption of platelets and coagulation factors leading to thrombocytopenia and coagulation abnormalities 4
  • Endothelial cell injury and dysfunction, which is a critical component of DIC pathophysiology 4
  • Microangiopathic hemolytic anemia with schistocytes (fragmented red blood cells) in peripheral blood smears 4
  • Fibrin-related marker elevation in plasma 4

The ISTH defines DIC as "an acquired syndrome characterized by the intravascular activation of coagulation with loss of localization arising from different causes. It can originate from and cause damage to the microvasculature, which if sufficiently severe, can produce organ dysfunction" 4.

In severe cases of DIC associated with purpura fulminans:

  • Extensive dermal vascular thrombosis with minimal inflammation 5
  • Failure of the anticoagulant protein C pathway leading to uncontrolled microvascular clotting 5
  • Hemorrhagic skin necrosis with epidermal necrosis and subepidermal vesiculation 5

Fulminant Hepatitis

Fulminant hepatitis has distinctive histopathological features that reflect the rapid and severe liver injury:

  • Panacinar hepatitis (parenchymal collapse), especially in biopsies performed during acute onset 4
  • Massive hepatocyte necrosis, which is a hallmark feature of fulminant hepatitis 4
  • Bridging necrosis connecting portal tracts and/or central veins 4
  • Pericentral (Rappaport zone 3) necrosis, which may resemble acute toxic injury 4
  • Inflammatory infiltrate that may include portal lymphoid follicles and plasma cell-enriched components 4
  • Central perivenulitis, which is particularly notable in cases of autoimmune fulminant hepatitis 4

In autoimmune fulminant hepatitis specifically:

  • Interface hepatitis with dense plasma cell-rich lymphoplasmocytic infiltrates 4
  • Hepatocellular rosette formation and emperipolesis (active penetration by one cell into and through a larger cell) 4
  • Hepatocyte swelling and/or pycnotic necrosis 4

Important Clinical Considerations

When evaluating these conditions, several important clinical considerations should be kept in mind:

  • Retiform purpura requires prompt biopsy for accurate diagnosis, as early recognition is essential to initiate appropriate treatment and prevent significant morbidity and mortality 1, 6
  • DIC diagnosis requires both clinical and laboratory assessment, with endothelial injury markers (such as antithrombin activity and von Willebrand factor) being important but often overlooked components 4
  • Fulminant hepatitis diagnosis often requires transjugular liver biopsy due to coagulopathy, and the histological pattern may evolve over time from pericentral hepatitis to interface hepatitis 4

The recognition of these distinctive histopathological patterns is crucial for early diagnosis and appropriate management of these potentially life-threatening conditions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.